NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

$2.77
+0.13 (+4.92%)
As of Feb 8, 2:28 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,364.6% upside
Low Target $36.99
Average Target $40.57
High Target $64.99
Current Price $2.77
Current
$2.77
Target
$40.57
$36.99 $40.57 avg $64.99
Scenario Analysis
Bear Case
$36.99
1,235.4%
Low target
Base Case
$40.57
+1,364.6%
Avg target
Bull Case
$64.99
+2,246.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$52.50
-94.7% from high
52-Week Low
$30.73
+-91.0% from low
Target vs 52W High
$40.57
-22.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%